Dr. Tapan Kadia is Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas. He serves as co-leader of the sections of AML and developmental therapeutics and is the the associate program director of the leukemia fellowship program. He is actively involved in clinical and translational research for the treatment of patients with leukemia. His particular focus is in developmental therapeutics in acute leukemia, including individualized frontline therapy, biologically rational targeted therapy, and longer term maintenance strategies in AML and ALL. He is primary investigator on numerous trials in acute myeloid leukemia, T-cell leukemias, bone marrow failure states, and is a leader in these. He has received numerous academic and clinical honors and awards for his studies and clinical research. Additionally, he’s authored over 425 peer-reviewed articles, numerous abstracts, and has been invited to speak nationally and internationally for presentation of his research.